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Abstract
Introduction: Herpes simplex infection is most commonly a benign, self-limiting disease with
mucocutaneous lesions and mild viremia. Immunosuppressed patients are at a higher risk of
disseminated infection, as are neonates and pregnant women. The incidence of fulminant herpes
simplex virus hepatitis is extremely low, and the diagnosis is often missed due to the lack of specific
signs or symptoms.
Case presentation: We present the case of an immunocompetent, previously healthy young
woman who contracted herpes simplex virus, presumably through a recent tongue piercing, which
progressed to fulminant hepatitis and death.
Conclusion: Despite aggressive medical therapy, fulminant herpes simplex virus hepatitis is fatal
in the majority of patients. We present a review of the literature, which shows that
immunocompetent adults have rarely been affected by fulminant herpes simplex virus hepatitis.
Initiation of empirical therapy is warranted in patients with progressive hepatic failure with no other
underlying cause. Acyclovir therapy has proven effective in some patients, but is less effective in
patients who present in advanced stages of infection.
Introduction
Herpes simplex infection is very common and affects all
ages. Most commonly, it presents as a benign, self-limit-
ing disease with mucocutaneous lesions and mild
viremia. Individuals who are immunocompromised,
neonates, and pregnant women are at a higher risk of
widespread disseminated infection including hepatitis.
The incidence of fulminant HSV hepatitis is extremely
low, and the diagnosis is often missed due to the lack of
specific signs or symptoms.
Case presentation
The patient was a 19-year-old Caucasian woman who pre-
sented to the clinic initially with nonspecific symptoms of
fatigue, fever and abdominal pain. Past medical history
was noncontributory; she was an otherwise healthy adult
from the United States, and did not report ill contacts,
intravenous drug use, or recent sexual contacts. She had a
temperature of 102.3°F, WBC of 4,800, AST of 330 U/liter
and ALT of 250 U/liter. She was thought at the time to
have a viral prodrome and was treated symptomatically.
The patient returned to the clinic 3 days later with resolu-
tion of her constitutional symptoms but with the develop-
ment of inflammation and pain around her recent tongue
piercing (1 to 2 weeks before this visit). The patient was
treated for oral thrush, and cultures of the tongue were
taken and grew normal oral flora and beta hemolytic
streptococci group C. Several days later, the patient pre-
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sented to the emergency room with worsening fever,
abdominal pain, vomiting, diarrhea, myalgia, and arthral-
gia. At this time, she had an AST of 6000 U/liter and ALT
of 4000 U/liter. The following day, her lab values
increased to an AST of 9200 U/liter and an ALT of 4400 U/
liter. Bilirubin and alkaline phosphatase were within nor-
mal limits. Other laboratory values were as follows: alco-
hol, non-detectable; CMV, infectious mononucleosis,
leptospira, EBV, HBV, HCV, HEV, HIV all negative; urine
drug screen negative; serum acetaminophen level of 3 μg/
dl.
CT scan showed a mottled liver and a 2 to 4 mm abscess
of the anterior tongue. Shortly after admission to the ICU,
she developed hypotension, coagulopathy with a PT of
83.2s and PTT of greater than 200s, hyperammonemia,
and acute renal failure thought to be due to hepatorenal
syndrome. The medical team was in the process of prepar-
ing her for transport to receive a liver transplant but the
patient expired. Postmortem laboratory results revealed a
tongue viral culture positive for HSV and a positive serum
HSV PCR.
Autopsy revealed a liver weighing 1620 g with diffuse geo-
graphic necrosis. Histological examination of the liver
showed extensive hemorrhagic necrosis with HSV intra-
nuclear inclusion (Figure 1), Cowdry type 1 and 2 (Figure
2), with immunoreactivity for HSV-1 (Figure 3). Other
findings included bilateral pleural effusions (approxi-
mately 500 ml) and a pelvic wall hematoma (4.0 × 2.5
cm).
Discussion
Herpes simplex virus (HSV) hepatitis occurs most com-
monly in the setting of immunocompromise, but has also
been reported in immunocompetent adults, children, and
Liver, medium power, demonstrating diffuse necrosis and loss of normal architecture Figure 1
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pregnant women [1-3]. To our knowledge, only seven
cases of fulminant hepatitis due to HSV in immunocom-
petent adults have been reported. However, it is likely that
many cases go undetected due to the nonspecific clinical
and laboratory presentation. Patients with HSV hepatitis
can present with a wide range of symptomatology, from
mild constitutional symptoms to severe coagulopathy
with loss of consciousness [4]. Early diagnosis of HSV
hepatitis is imperative in order to institute treatment in a
timely manner. The mortality rate is high among
untreated patients [5]. In one review, only 23% of
reported patients were diagnosed antemortem [6].
Untreated herpes hepatitis is associated with mortality in
80% to 90% of cases [7].
Early initiation of antiviral therapy, especially acyclovir,
can improve chances of survival [8,9].
There is no diagnostic pattern to the presentation of HSV
hepatitis. Patients present with symptoms such as fever
and abdominal pain in combination with rising ALT and
AST titers [3,10]. In a review of 137 cases of HSV hepatitis,
the most common presenting features were fever (98%),
coagulopathy (84%), and encephalopathy (80%). Rash
was seen in less than half of patients [11]. Over half of
cases (58%) were first diagnosed at autopsy, and three-
quarters of the cases (74%) progressed to death or liver
transplantation. Other abnormalities that may be present
in patients with HSV hepatitis include leukopenia, sero-
logical evidence of infection, and mucocutaneous lesions,
but these factors are not present in all patients.
Fulminant HSV hepatitis is usually marked by significant
elevations in transaminases, with AST typically higher
than ALT, and a mild or absent hyperbilirubinemia. Sero-
Liver, high power, demonstrating Cowdry bodies within hepatocytes Figure 2
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logical testing for HSV-IgM and -IgG is often negative,
however, it does not rule out HSV as the underlying etiol-
ogy.
Definitive diagnosis is made by liver biopsy, with demon-
stration of hepatic necrosis, HSV cytopathic effects, and
immunoreactivity to HSV [3]. Viral blood cultures will not
provide timely results, and real-time PCR testing for
viremia, which can provide results in 3 hours [12], is not
available at every center.
Levels of ALT and AST correlate with survival. A greater
than 100-fold increase in ALT and AST was associated
with fatality in 100% of patients in one review [12]. Liver
biopsy and blood cultures should be performed, before
initiation of antiviral therapy, but empiric therapy should
be instituted immediately in patients with no other
known reason for hepatic failure.
Biopsy will demonstrate diffuse hepatic necrosis with
hemorrhage, and may demonstrate Cowdry type 1 and 2
inclusions. Collapse of the normal architecture with loss
of the reticulin framework will be present. A lymphocytic
infiltration may be seen, but is usually modest. Immunos-
taining for HSV will detect the presence of the virus within
the hepatocyte cytoplasm. Blood cultures provide sup-
portive evidence to the diagnosis.
A high index of suspicion is necessary when a patient
presents with constitutional symptoms and elevating AST
and ALT, and these findings should prompt immediate
antiviral therapy with acyclovir. Risk factors for HSV hep-
atitis include third trimester pregnancy and immunosup-
pression. The degree of elevation of AST and ALT should
be taken into account, because many viral illnesses,
including primary HSV infection, can produce mild eleva-
tions in liver enzymes without progression to fulminant
Liver, high power, immunohistochemical staining for HSV-1, demonstrating diffuse positivity Figure 3
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hepatitis. Serial evaluation of these values will show con-
sistent increase when hepatic damage is severe, and
should prompt immediate intervention. Even in the
absence of direct evidence of acute HSV infection, admin-
istration of acyclovir is a relatively safe treatment. While
fulminant hepatitis is only rarely due to HSV, the fact that
this infection often responds to antivirals early in its
course warrants empirical treatment. Despite this, there
has been a report of acyclovir-resistant HSV hepatitis [13].
Body piercing is a known risk factor for HSV infection. A
review by Hayes and Harkness reported HSV infection
and/or seroconversion to be associated with percutaneous
needle exposure and body piercing [14]. These findings
indicate the need for public health intervention, including
education and regulation of body piercing practices, in
order to prevent transmission of HSV.
Conclusion
Clinicians should have a high index of suspicion for HSV
hepatitis in both immunocompetent and immunocom-
promised patients with elevated liver enzymes and no
other underlying disease. Fulminate hepatitis may occur
without evidence of primary HSV infection. Acyclovir
treatment should be initiated early in cases of hepatitis of
unknown etiology, as early initiation of therapy is imper-
ative to prevent severe disease resulting in liver transplan-
tation or death.
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